Vijaya Diagnostic Centre Limited (NSE: VIJAYA) shows a 5% intraday fall to ₹1334.3, retracing post-breakout gains in the Healthcare & Diagnostics sector.
Thyrocare Technologies Limited (NSE: THYROCARE) stock gains 5% intraday, trading at ₹537.5 despite a breakdown trendline status.
Vijaya Diagnostic Centre Limited (NSE: VIJAYA) stock rises 5% intraday to ₹1378.0, showing a recovery bounce despite a 6M trendline breakdown..
Vijaya Diagnostic Centre Limited (NSE: VIJAYA) drops 5% intraday to ₹1294.0, with the stock still in breakdown trendline status..
Thyrocare Technologies Limited (NSE: THYROCARE) stock moves down 5% intraday at ₹527.15, retracing after clearing resistance in the Healthcare > Diagnostics.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 10% intraday. The stock cleared its 6M resistance trendline, marking a strong upward move in th.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock clears its 6M resistance trendline, gaining 10% intraday. This breakout signals a strong upward trend in the health.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown..
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 9% intraday. The stock cleared its 6M resistance trendline, signaling a strong upward move in t.